New York, NY -- (SBWIRE) -- 05/06/2021 -- The global Cell Therapy Market is forecast to reach USD 8.75 Billion by 2027, according to a new report by Reports and Data. The market for cell therapy is observing a high demand due to the rise in the number of clinical trials across the world. These therapies are used in regenerative medicine, especially for degenerative and immunogenic pathologies. However, the applications of cell therapy in oncology will experience higher growth, owing to a large number of pipeline projects for the treatment of tumors or cancer.

The inception of effective guidelines for cell therapy manufacturing, the development of advanced genomic analysis techniques, a vast number of research by cancer societies, and proven effectiveness of transplants are some of the primary growth stimulants for the market. Certain pharmacological and manufacturing issues and regulatory hurdles are restricting the growth of the market.

The Japanese government has recognized cell therapy and regenerative medicine as a major donor to the country's economic growth. This has influenced the attention of global market players towards the Asian market, thereby fostering marketing operations in the region.

Many deals and new companies are coming up to boost the research in cell therapy. UK Biotech startup Bit Bio received a €36.9 million Series A funding, in June 2020, to boost the manufacturing efficiency of human cells for application in cell therapy and drug discovery.

The COVID-19 impact:
The market for cell therapy will witness a surge in demand as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A remarkable number of biotech firms are in the midst of the race to scrutinize the virus's genome and are trying to develop a viable vaccine. These companies are investigating the virus at an unparalleled rate, and considerable funds are being invested into the research. The companies are in trial, and the private and public sectors are working continuously for the development of the vaccine.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3269

Further key findings from the report suggest:
Allogeneic Stem Cell Therapy dominated the therapy type segment. The segment is advantageous as they produce their own immune stem cells, which can kill cancer cells that remain even after high-dose cytotoxic drugs treatment. The patients those have a high risk of relapse after successful treatment of chemotherapy are recommended allogeneic transplants. The rising cases of cancer relapse have fueled the demand for the segment.

Stem cell banking is gaining popularity from the initiatives taken by the government. The number of stem cell banks are increasing in developing nations, which is further propelling market growth. Also, increasing awareness regarding the storage of stem cells has had a positive effect on the market. The market is still at a nascent stage, but it holds potential in both therapeutic and diagnosis fields.

Hospitals and clinics are forecasted to grow at a significant CAGR of 5.8% during the forecast period. The lucrative growth in the segment is due to the increase in the number of pipeline projects over the past few years. As per the Cancer Research Institute (CRI), the number of projects rose from 753 in 2018 to 1,011 in 2019.

Cell therapy has been observed to induce profound healing activity in animals with different forms of autoimmune disorders. Besides healing damaged tissues, it has the unique ability to modulate the immune system while preserving its ability to fight off disease.

North America is anticipated to account for a significant share of the global cell therapy market. The United States will be the major contributor and is expected to witness high growth owing to the huge amount of funding by the government and private firms for clinical trials.

Key participants include JCR Pharmaceuticals Co. Ltd., Fibrocell Science, Inc., Kolon TissueGene, Inc., Osiris Therapeutics, Inc., PHARMICELL Co., Ltd., MEDIPOST, Stemedica Cell Technologies, Inc., Cells for Cells, Vericel Corporation, and ANTEROGEN Co., Ltd., among others.

For the purpose of this report, Reports and Data have segmented the global Cell Therapy Market on the basis of therapy type, therapeutic area, cell type, end-user, and region:

Therapy Type Outlook (Revenue, USD Billion; 2017-2027)
Allogenic Stem Cell Therapy
Autologous Stem Cell Therapy

Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027)
Malignancies
Autoimmune Disorders
Musculoskeletal Disorders
Dermatology
Others

Cell Type Outlook (Revenue, USD Billion; 2017-2027)
Stem Cells
Non-Stem Cells

End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Academic & Research Institutes

Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
S
Canada
Europe
Germany
K
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3269

Key questions addressed in the report are:
What is the estimated market size and share in the forecast period?
What are the key driving factors of the Global Cell Therapy Market?
What are the risks and challenges the companies will have to face in the forecast period?
What are the emerging trends, and how will they influence market growth?
What are the opportunities for expansion of the global Cell Therapy Market?
Which region is expected to dominate the market during the forecast period?

Table of Contents:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Cell Therapy Market Segmentation & Impact Analysis
4.1. Cell Therapy Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increase in adoption of regenerative medicine
4.2.2.2. Introduction of new technologies
4.2.3. Market restraints analysis
4.2.3.1. Ethical reasons related to stem cell research
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter's Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence

Chapter 5. Cell Therapy Market By Therapy Type Insights & Trends
5.1. Therapy Type Dynamics & Market Share, 2019 & 2027
5.2. Allogenic Stem Cell Therapy
5.2.1. Market estimates and forecast, 2017 – 2027 (USD Billion)
5.2.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion)
5.3. Autologous Stem Cell Therapy
5.3.1. Market estimates and forecast, 2017 – 2027 (USD Billion)
5.3.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion)

Chapter 6. Cell Therapy Market By Therapeutic Area Insights & Trends

Continued…..